A nurse is assisting with the care of an adolescent. Which of the following statements should the nurse identify as high-risk behaviors?

A) I will take my inhaler treatment before each meal and at bedtime:
Budesonide is a corticosteroid inhaler used for asthma management, but it is not specifically required to be taken before meals. The timing of inhaler use should be directed by the healthcare provider based on the individual treatment plan. Taking the inhaler at meals is not typically necessary unless specifically instructed, and there is no standard requirement for it to be taken at bedtime either.

B) I will rinse my mouth and gargle with water after each inhaler treatment:
Rinsing the mouth and gargling with water after using an inhaled corticosteroid, like budesonide, is an essential step to reduce the risk of developing oral thrush, a fungal infection. Corticosteroids can promote fungal growth in the mouth, so rinsing helps to clear any residual medication from the mouth and prevent this complication. This statement demonstrates an accurate understanding of the proper use of the inhaler.

C) I should use my inhaler when I have an asthma attack:
Budesonide is a maintenance medication used to control asthma symptoms over the long term, not for immediate relief during an asthma attack. For acute asthma attacks, a fast-acting bronchodilator like albuterol is used, not a corticosteroid like budesonide. The adolescent’s statement reflects a misunderstanding of the purpose of budesonide, which is for prevention and long-term control.

D) I should use my inhaler before exercising:
Using an inhaler before exercise may be appropriate for clients who have exercise-induced bronchoconstriction or asthma, but budesonide is not typically used as a pre-exercise medication. Instead, a short-acting bronchodilator is used before exercise to prevent asthma symptoms during activity. Budesonide is generally used for long-term asthma management rather than for acute symptom relief.

A) Decreased hemoglobin level: A decreased hemoglobin level is not an expected or desirable outcome of taking furosemide. While furosemide can cause fluid loss, it does not directly affect red blood cell production or hemoglobin levels. A decrease in hemoglobin could indicate anemia or another underlying issue, which should be addressed separately.

B) Increased weight of 0.91 kg (2 lb): An increase in weight, especially in a client with heart failure, could indicate fluid retention rather than effective diuresis. Furosemide is a diuretic that helps reduce fluid buildup, so an increase in weight would typically suggest that the medication is not effectively managing fluid overload, which is a key issue in heart failure.

C) Increased urinary output: An increase in urinary output is a clear indicator that furosemide is working effectively. Furosemide is a loop diuretic, which promotes the excretion of sodium and water, leading to increased urine output. This helps reduce fluid volume in the body, which is beneficial for a client with heart failure.

D) Decreased BUN level: While furosemide can affect kidney function, a decrease in blood urea nitrogen (BUN) level is not a direct indicator of the medication’s effectiveness. BUN can be influenced by various factors such as hydration status, kidney function, and protein intake. A decreased BUN level does not directly correlate with furosemide's effectiveness in treating heart failure.